Chemistry: molecular biology and microbiology – Vector – per se
Patent
1995-05-23
1997-11-04
Robinson, Douglas W.
Chemistry: molecular biology and microbiology
Vector, per se
4352401, C12N 1563, C12N 500
Patent
active
056839057
ABSTRACT:
A recombinant DNA vector is provided that expresses exons of genomic DNA fragments that are inserted into the vector. The vector contains a promoter and a genomic DNA fragment so characterized and configured that the vector, upon transcription in a transfected eukaryotic cell culture, expresses the corresponding RNA segment of the genomic DNA fragment free of any intron.
REFERENCES:
patent: Re32011 (1985-10-01), Zimmerman et al.
patent: 4027013 (1977-05-01), Bick et al.
patent: 4069216 (1978-01-01), Shanbrom
patent: 4085095 (1978-04-01), Bick et al.
patent: 4093608 (1978-06-01), Iga et al.
patent: 4104266 (1978-08-01), Wickerhauser
patent: 4188318 (1980-02-01), Shanbrom
patent: 4221780 (1980-09-01), Cort
patent: 4289691 (1981-09-01), Rock
patent: 4294826 (1981-10-01), Feldman
patent: 4341764 (1982-07-01), Wallace et al.
patent: 4348315 (1982-09-01), Blomback et al.
patent: 4359463 (1982-11-01), Rock
patent: 4361509 (1982-11-01), Zimmerman et al.
patent: 4387092 (1983-06-01), Liautaud et al.
patent: 4396601 (1983-08-01), Salser et al.
patent: 4399216 (1983-08-01), Axel et al.
patent: 4404131 (1983-09-01), Schwarz et al.
patent: 4495175 (1985-01-01), Chavin et al.
patent: 4508709 (1985-04-01), Amphlett et al.
patent: 4522751 (1985-06-01), Linnau et al.
patent: 4556558 (1985-12-01), Rubinstein
patent: 4614795 (1986-09-01), Chavin et al.
patent: 4632981 (1986-12-01), Bock et al.
patent: 4657894 (1987-04-01), Zimmerman et al.
patent: 4659805 (1987-04-01), Schilling, Jr. et al.
patent: 4757006 (1988-07-01), Toole, Jr. et al.
patent: 4879226 (1989-11-01), Wallace et al.
patent: 4965199 (1990-10-01), Capon et al.
patent: 5004804 (1991-04-01), Kuo et al.
patent: 5101016 (1992-03-01), Zimmerman et al.
patent: 5252475 (1993-10-01), Reth
patent: 5498531 (1996-03-01), Jarrell
patent: 5561053 (1996-10-01), Crowley
Hamer et al. Splicing and the Formation of Stable RNA. Cell 18:1299-1302. 1979.
Okayama et al. A cDNA Cloning Vector that Permits Expression of cDNA Inserts in Mammalian Cells. Molecular and Cellular Biology 3(2):280-289. 1983.
Nexis Report, Business Week (Feb. 16, 1987).
Biotechnology Law Report 6:389-390 (Sep.-Oct. 1987).
Nexis Report, Business Week (Apr. 13, 1987).
Nexis Report, Genetic Technology News (Nov. 1987).
Newswatch 7(21):5-6 (Nov. 2, 1987).
FDC Reports 50(18):T&G-12 (May 2, 1988).
Monoclate R Product Disclosure.
Andersson et al., "Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma" Proc. Natl. Acad. Sci. USA 83 (9):2979-2983 (1986).
Beck et al., "Nucleotide sequence and exact localization of the neomycin phosphotransferase gene from transposon Tn5" Gene 19(3):327-336 (1982).
Brownlee and Rizza, "Clotting factor VIII cloned" Nature 312 (5992):307 (1984).
Choo et al., "Vectors for expression and amplification of cDNA in mammalian cells: expression of rat phenylalanine hydroxylase" DNA 5(6):529-537 (1986).
de Saint Vincent et al., "The cloning and reintroduction into animal cells of a functional CAD gene, a dominant amplifiable genetic marker" Cell 27(1):267-277 (Dec. 1981).
Eaton et al., "Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity" Biochemistry 25(2):505-512 (1986).
Fass et al., "Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant protein" Blood 59(3):594-600 (1982).
Fay et al., "The effect of carbohydrate depletion on procoagulant activity and in vivo survival of highly purified human factor VIII" Biochimica et Biophysica Acta 800(2):152-158 (Jul. 1984).
Fay et al., "Propolypeptide of von Willebrand factor circulates in blood and is identical to von Willebrand antigen II" Science 232:995-998 (May 1986).
Fay et al., "Purification and characterization of a highly purified human factor VIII consisting of a single type of polypeptide chain" Proc. Natl. Acad. Sci. USA 79 (23):7200-7204 (Dec. 1982).
Fay et al., "The size of human factor VIII heterodimers and the effects produced by thrombin" Biochimica et Biophysica Acta 871 (3):268-278 (Jun. 1986).
Fulcher & Zimmerman, "Characterization of the human factor VIII procoagulant protein with a heterologous precipitating antibody" Proc. Natl. Acad. Sci. USA 79 (5):1648-1652 (Mar. 1982).
Giri et al., "Comparative studies of the expression of linked Escherichia coli gpt gene and BPV-1 DNAs in transfected cells" Virology 127 (2):385-396 (Jun. 1983).
Gitschier et al., "Characterization of the human factor VIII gene" Nature 312:326-330 (Nov. 1984).
Haber et al., "Chromosome-Mediated Transfer and Amplification of an Altered Mouse Dihydrofolate Reductase Gene" Somatic Cell Genetics 8 (4):499-508 (1982).
Harris, "Isolation and characterization of low molecular weight non-aggregated antihemophelic factor from fresh human plasma" (Dissertation Abstract) (1979).
Hoyer and Trabold, "The effect of thrombin on human factor VIII" J. Laboratory and clin. Med. 97 (1):50-64 (1981).
Kaufman, "Construction of a Modular Dyhydrofolate Reductase cDNA Gene: Analysis of Signals Utilized for Efficient Expression" Molecular & Cellular Biology 2 (11):1304-1319 (1982).
Kaufman et al., "Amplification and Expression of Sequences Cotransfected with a Modular Dihydrofolate Reductase Complementary DNA Gene" J. Mol. Biol. 159:601-621 (1992).
Kaufman et al., "Selection and amplification of heterologous genes encoding adenosine deaminase in mammalian cells" Proc. Natl. Acad. Sci. USA 83 (10):3136-3140 (May 1986).
Kaufman et al., "Site-specific mutagenesis to study the structure and function of factor VIII" Journal of Cellular Biochemistry Supplement (UCLA Symposia on Molecular & Cellular Biology, Jan. 20, 1986-Feb. 15, 1986), New York:Alan R. Liss, Inc. vol. 10A:275 (1986).
Kemp et al., "Stable mutants of mammalian cells that overproduce the first three enzymes of pyrimidine nucleotide biosynthesis" Cell 9 (4):541-550 (Dec. 1976).
Knutson and Fass, "Porcine factor VIII:C prepared by affinity interaction with von Willebrand factor and heterologous antibodies: sodium dodecyl sulfate polyacrylamide gel analysis" Blood 59 (3):615-624 (1982).
Legaz et al., "Isolation and characterization of human Factor VIII (antihemophilic factor)" Journal of Biological Chemistry 248 (11):3946-3955 (Jun. 1973).
Maddox, "Who will clone a chromosome?" Nature 312 (22):306 (1984).
McConlogue et al., "Molecular cloning and expression of the mouse ornithine decarboxylase gene" Proc. Natl. Acad. Sci. USA 81 (2):540-544 (Jan. 1984).
Milbrandt et al., "Amplification of a cloned Chinese hamster dihydrofolate reductase gene after transfer into a dihydrofolate reductase-deficient cell line" Molecular & Cellular Biology 3 (7):1274-1282 (Jul. 1983).
Murray et al., "Construction and use of a dominant, selectable marker: a Harvey sarcoma virus-dihydrofolate reductase chimera" Molecular & Cellular Biology 3 (1):32-43 (Jan. 1983).
Norris et al., "Efficient site-directed mutagenesis by simultaneous use of two primers" Nucleic Acids Research 11 (15):5103-5112 (1983).
Orr et al., Thrombosis Haemostasis 54 (1):54 (1985).
Ringold et al., "Co-expression and Amplification of Dihydrofolate Reductase cDNA and the Escherichia coli XGPRT Gene in Chinese Hamster Ovary Cells" Journal of Molecular & Applied Genetics 1 (3):165-175 (1981).
Schoner and Littlefield, "The organization of the dihydrofolate reductase gene of baby hamster kidney fibroblasts" Nucleic Acids Research 9 (23):6601-6614 (1981).
Simonsen and Levinson, "Isolation and expression of an altered mouse dihydrofolate reductase cDNa" Proc. Natl. Acad. Sci. USA 80 (9):2495-2499 (1983).
Stel et al., "Detection of factor VIII coagulant antigen in human liver tissue" Nature (Abstract only) 303:530-532 (1983).
Toole et al., "A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity" Proc. Natl. Acad. Sci. USA 83 (16):5939-5942 (Aug. 1986).
Toole et al., "Molecular cloning of a cDNA encoding human antihaemophilic facto
Capon Daniel J.
Lawn Richard M.
Vehar Gordon A.
Wood William I.
Genentech Inc.
Hasak Janet E.
McNicholas Janet M.
Robinson Douglas W.
Wai Thanda
LandOfFree
Vectors and cell lines capable of correctly splicing exon region does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Vectors and cell lines capable of correctly splicing exon region, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Vectors and cell lines capable of correctly splicing exon region will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1832371